Alessandra Musso

837 total citations
16 papers, 665 citations indexed

About

Alessandra Musso is a scholar working on Immunology, Oncology and Neurology. According to data from OpenAlex, Alessandra Musso has authored 16 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Oncology and 4 papers in Neurology. Recurrent topics in Alessandra Musso's work include Immune Cell Function and Interaction (8 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and T-cell and B-cell Immunology (4 papers). Alessandra Musso is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and T-cell and B-cell Immunology (4 papers). Alessandra Musso collaborates with scholars based in Italy, United States and Switzerland. Alessandra Musso's co-authors include Alessandro Poggi, Maria Raffaella Zocchi, Darren J. Moore, Silvia Boero, Liliane Glauser, Saskia Biskup, Valina L. Dawson, Ted M. Dawson, Silvia Catellani and Roger Moser and has published in prestigious journals such as Blood, PLoS ONE and Annals of the New York Academy of Sciences.

In The Last Decade

Alessandra Musso

16 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandra Musso Italy 14 248 213 197 178 94 16 665
Czrina Cortez United States 7 451 1.8× 217 1.0× 398 2.0× 265 1.5× 59 0.6× 9 891
Steven Perrin United States 12 222 0.9× 225 1.1× 79 0.4× 196 1.1× 80 0.9× 17 656
Abhik Ray Chaudhury United States 17 355 1.4× 144 0.7× 401 2.0× 419 2.4× 105 1.1× 26 1.0k
Monica Z. Wang United States 9 171 0.7× 159 0.7× 74 0.4× 460 2.6× 48 0.5× 10 942
Yazhong Tao United States 13 249 1.0× 146 0.7× 129 0.7× 689 3.9× 117 1.2× 15 1.2k
Bettina Sobottka Switzerland 13 185 0.7× 49 0.2× 226 1.1× 225 1.3× 42 0.4× 24 692
Caterina Marchetti Italy 7 121 0.5× 228 1.1× 179 0.9× 748 4.2× 143 1.5× 8 1.1k
Ulrike Tontsch Austria 13 159 0.6× 92 0.4× 150 0.8× 280 1.6× 50 0.5× 17 714
Marloes van Zwam Netherlands 10 333 1.3× 71 0.3× 109 0.6× 190 1.1× 40 0.4× 11 743
Yumiko Azuma Japan 14 105 0.4× 173 0.8× 31 0.2× 233 1.3× 61 0.6× 33 487

Countries citing papers authored by Alessandra Musso

Since Specialization
Citations

This map shows the geographic impact of Alessandra Musso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Musso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Musso more than expected).

Fields of papers citing papers by Alessandra Musso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Musso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Musso. The network helps show where Alessandra Musso may publish in the future.

Co-authorship network of co-authors of Alessandra Musso

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Musso. A scholar is included among the top collaborators of Alessandra Musso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Musso. Alessandra Musso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zocchi, Maria Raffaella, Caterina Camodeca, Elisa Nuti, et al.. (2015). ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing. OncoImmunology. 5(5). e1123367–e1123367. 40 indexed citations
2.
Poggi, Alessandro, et al.. (2014). Mechanisms of tumor escape from immune system: Role of mesenchymal stromal cells. Immunology Letters. 159(1-2). 55–72. 106 indexed citations
3.
Daniel, Guillaume, Alessandra Musso, Elpida Tsika, et al.. (2014). α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9). Neurobiology of Disease. 73. 229–243. 27 indexed citations
4.
Stafa, Klodjan, Elpida Tsika, Roger Moser, et al.. (2013). Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily. Human Molecular Genetics. 23(8). 2055–2077. 106 indexed citations
5.
Poggi, Alessandro, Silvia Boero, Alessandra Musso, & Maria Raffaella Zocchi. (2013). Selective Role of Mevalonate Pathway in Regulating Perforin but Not FasL and TNFalpha Release in Human Natural Killer Cells. PLoS ONE. 8(5). e62932–e62932. 16 indexed citations
6.
Amaro, Adriana, Valentina Mirisola, Giovanna Angelini, et al.. (2013). Evidence of epidermal growth factor receptor expression in uveal melanoma: Inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity. European Journal of Cancer. 49(15). 3353–3365. 38 indexed citations
7.
Musso, Alessandra, Silvia Catellani, Paolo Canevali, et al.. (2013). Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor V  2 T lymphocytes in non-Hodgkin lymphomas. Haematologica. 99(1). 131–139. 26 indexed citations
8.
Daher, João Paulo Lima, Olga Pletniková, Saskia Biskup, et al.. (2012). Neurodegenerative phenotypes in an A53T  -synuclein transgenic mouse model are independent of LRRK2. Human Molecular Genetics. 21(11). 2420–2431. 75 indexed citations
9.
Musso, Alessandra, Alžbeta Trančíková, Klodjan Stafa, et al.. (2012). Common Pathogenic Effects of Missense Mutations in the P-Type ATPase ATP13A2 (PARK9) Associated with Early-Onset Parkinsonism. PLoS ONE. 7(6). e39942–e39942. 44 indexed citations
10.
Zocchi, Maria Raffaella, Silvia Catellani, Paolo Canevali, et al.. (2011). High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas. Blood. 119(6). 1479–1489. 75 indexed citations
11.
Poggi, Alessandro, Alessandra Musso, Silvia Boero, Paolo Canevali, & Maria Raffaella Zocchi. (2010). Statins as Either Immunomodulators or Anti-Cancer Drugs: Functional Activities on Tumor Stromal Cells and Natural Killer Cells. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 9(1). 82–92. 2 indexed citations
12.
Poggi, Alessandro, Marta Zancolli, Silvia Boero, et al.. (2010). Differential survival of γδT cells, αβT cells and NK cells upon engagement of NKG2D by NKG2DL‐expressing leukemic cells. International Journal of Cancer. 129(2). 387–396. 12 indexed citations
13.
Musso, Alessandra, Maria Raffaella Zocchi, & Alessandro Poggi. (2010). Relevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T-cell proliferation and B-cell survival. Haematologica. 96(1). 16–23. 33 indexed citations
14.
Poggi, Alessandro, Silvia Catellani, Alessandra Musso, & Maria Raffaella Zocchi. (2009). Gammadelta T Lymphocytes Producing IFNγ and IL-17 in Response to Candida Albicans or Mycobacterial Antigens: Possible Implications for Acute and Chronic Inflammation. Current Medicinal Chemistry. 16(35). 4743–4749. 24 indexed citations
15.
Ghio, Massimo, Paola Contini, Simone Negrini, et al.. (2009). Soluble HLA‐I‐mediated secretion of TGF‐β1 by human NK cells and consequent down‐regulation of anti‐tumor cytolytic activity. European Journal of Immunology. 39(12). 3459–3468. 22 indexed citations
16.
Poggi, Alessandro, Claudia Prevosto, Marta Zancolli, et al.. (2007). NKG2D and Natural Cytotoxicity Receptors Are Involved in Natural Killer Cell Interaction with Self‐Antigen Presenting Cells and Stromal Cells. Annals of the New York Academy of Sciences. 1109(1). 47–57. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026